Remedis SA (WSE:REM) made an offer to acquire 78.05% stake in Hdomedical SP. Z O.O from Skyline Venture Sp. z o.o for PLN 5.5 million on June 23, 2017. As part of transaction, Remedis will acquire 0.01 million shares of Hdomedical. As of October 18, 2017, Remedis shall obtain an approval of their corporate bodies to conduct transactions, in particular the supervisory board. The process of negotiating the terms of the transaction will be completed and the transaction will be settled by December 31, 2017. As on October 16, 2017, Skyline Venture obtained the consent of the Investment Committee for the sale of shares of HDOMedical Sp. Remedis SA (WSE:REM) cancelled the acquisition of 78.05% stake in Hdomedical SP. Z O.O from Skyline Venture Sp. z o.o on June 23, 2018.